Evidence map›Paper›PMID 34669096›Full record

Trial reportFamilial cancer2022

Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.

Luigina Bonelli, Ivana Valle, Ivana Rebora, Paola Ricci, Lidia Biocchi, Giovanna Bruschi, Sabrina Parodi, Carla Bruzzone, Liliana Varesco

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Familial cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Luigina BonelliUnit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. luiginaada.bonelli@hsanmartino.it.ORCID http://orcid.org/0000-0002-9034-9630
Ivana ValleDepartment of Prevention, ASL3-Liguria, Genoa, Italy.
Ivana ReboraDepartment of Prevention, ASL3-Liguria, Genoa, Italy.
Paola RicciUnit of Screening Evaluation and Organization, ASL3-Liguria, Genoa, Italy.
Lidia BiocchiUnit of Screening Evaluation and Organization, ASL3-Liguria, Genoa, Italy.
Giovanna BruschiUnit of Screening Evaluation and Organization, ASL3-Liguria, Genoa, Italy.
Sabrina ParodiUnit of Screening Evaluation and Organization, ASL3-Liguria, Genoa, Italy.
Carla BruzzoneUnit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Liliana VarescoUnit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID http://orcid.org/0000-0003-4871-6668
Ospedale Policlinico San Martino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women attending mammography screening may benefit from family history (FH) assessment for the identification of Hereditary Breast Ovarian Cancer (HBOC). Few studies explored the efficacy of tailored educational interventions in driving the attention on FH-associated risk among these women. To compare the efficacy of two educational tools in increasing attention towards FH, 6.802 women with a negative mammography were randomized to receive a note on FH of breast/ovarian cancer (letter A, n = 3.402) or a note with details on possible implication of FH patterns (letter B, n = 3.200). Upon women's request, a brief questionnaire was administered on phone at the Screening Unit (S.U.) to select those eligible for an in-depth FH evaluation at the Genetic Unit (G.U.). Each affected relative was scored 1-3 according to type of cancer, age at diagnosis, gender, position in the family tree. In all, 401 women contacted the S.U.: 244 (6.6%) in group A and 177 (5.2%) in group B (adjOR 1.27; 95%CI 1.03-1.56). FH scored ≥ 3 for 164 women: 177 (47.5%) in group B and 224 (35.7%) in group A, (adjOR 1.59, 95%CI 1.06-2.38). The G.U. traced and interviewed 148 women, 65 (43.9%) were offered an in-person consultation: 38 attended and 30 were eligible for testing. A test was performed for 24 women: no BRCA pathogenic variant was found. Among mammographic screening attendees, educational material with a simple description of FH may improve self-referral of women deserving an in-depth evaluation for HBOC identification. Additional educational efforts are needed to enhance the efficiency of the intervention.

Indexed as

Breast NeoplasmsOvarian NeoplasmsCarcinoma, Ovarian EpithelialEarly Detection of CancerFemaleGenetic Predisposition to DiseaseHumansMammographyGenetic counselling/testingGenetic literacyHereditary breast–ovarian cancerPopulation-based breast cancer screeningRisk assessmentWomen information

Identifiers

PMID34669096
OpenAlexW3206550873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.